{"count": 12, "results": [{"_id": "35802672", "pmid": 35802672, "pmcid": "PMC9269956", "title": "Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium", "journal": "PLoS One", "authors": ["Li Y", "Gappy S", "Liu X", "Sassalos T", "Zhou T", "Hsu A", "Zhang A", "Edwards PA", "Gao H", "Qiao X"], "date": "2022-07-08T00:00:00Z", "doi": "10.1371/journal.pone.0268451", "meta_date_publication": "2022", "meta_volume": "17", "meta_issue": "7", "meta_pages": "e0268451", "score": 50270.74, "text_hl": "...Non-met @<m>DISEASE_603933</m> @DISEASE_OMIM:603933 @@@PDR@@@ = non-@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ treated @<m>DISEASE_603933</m> @DISEASE_OMIM:603933 @@@PDR@@@ group", "citations": {"NLM": "Li Y, Gappy S, Liu X, Sassalos T, Zhou T, Hsu A, Zhang A, Edwards PA, Gao H, Qiao X. Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium PLoS One. 2022;17(7):e0268451. PMID: 35802672", "BibTeX": "@article{35802672, title={Metformin suppresses pro-inflammatory cytokines in vitreous of diabetes patients and human retinal vascular endothelium}, author={Li Y and Gappy S and Liu X and Sassalos T and Zhou T and Hsu A and Zhang A and Edwards PA and Gao H and Qiao X}, journal={PLoS One}, volume={17}, number={7}, pages={e0268451}}"}}, {"_id": "40182582", "pmid": 40182582, "title": "The association between duration of metformin and sulfonylurea treatment and microvascular complications in patients with incident type 2 diabetes: a pooled cohort analysis.", "journal": "J Diabetes Metab Disord", "authors": ["Bahardoust M", "Mehrabi Y", "Hadaegh F", "Azizi F", "Khalili D", "Delpisheh A"], "date": "2025-04-01T00:00:00Z", "doi": "10.1007/s40200-025-01577-w", "meta_date_publication": "2025 Jun", "meta_volume": "24", "meta_issue": "1", "meta_pages": "94", "score": 50258.63, "text_hl": "The aim of this study was to investigate the association of medication time with @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ and SUs and @<m>DISEASE_603933</m> @DISEASE_OMIM:603933 @@@microvascular complications@@@ in newly diagnosed @DISEASE_Myotonic_Dystrophy @DISEASE_MESH:D009223 @@@DM2@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Bahardoust M, Mehrabi Y, Hadaegh F, Azizi F, Khalili D, Delpisheh A. The association between duration of metformin and sulfonylurea treatment and microvascular complications in patients with incident type 2 diabetes: a pooled cohort analysis. J Diabetes Metab Disord. 2025 Jun;24(1):94. PMID: 40182582", "BibTeX": "@article{40182582, title={The association between duration of metformin and sulfonylurea treatment and microvascular complications in patients with incident type 2 diabetes: a pooled cohort analysis.}, author={Bahardoust M and Mehrabi Y and Hadaegh F and Azizi F and Khalili D and Delpisheh A}, journal={J Diabetes Metab Disord}, volume={24}, number={1}, pages={94}}"}}, {"_id": "36944068", "pmid": 36944068, "title": "Evaluating the Effect of Hypoglycemic Agents on Diabetic Retinopathy Progression.", "journal": "Ophthalmic Surg Lasers Imaging Retina", "authors": ["Wai KM", "Saroj N", "Boucher N", "Aggarwal N", "Ho AC", "Rahimy E"], "date": "2023-03-01T00:00:00Z", "doi": "10.3928/23258160-20230217-02", "meta_date_publication": "2023 Mar", "meta_volume": "54", "meta_issue": "3", "meta_pages": "158-165", "score": 50252.867, "text_hl": "Progression rates from moderate @DISEASE_612635 @DISEASE_OMIM:612635 @@@NPDR@@@ to severe @DISEASE_612635 @DISEASE_OMIM:612635 @@@NPDR@@@ or @<m>DISEASE_603933</m> @DISEASE_OMIM:603933 @@@PDR@@@ were the following: @GENE_DPP4 @GENE_1803 @@@DPP-4@@@ (11%), @GENE_SLC5A2 @GENE_6524 @@@SGLT-2@@@ (10%), GLP-1 (11%), @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (10%), none (13%). ", "citations": {"NLM": "Wai KM, Saroj N, Boucher N, Aggarwal N, Ho AC, Rahimy E. Evaluating the Effect of Hypoglycemic Agents on Diabetic Retinopathy Progression. Ophthalmic Surg Lasers Imaging Retina. 2023 Mar;54(3):158-165. PMID: 36944068", "BibTeX": "@article{36944068, title={Evaluating the Effect of Hypoglycemic Agents on Diabetic Retinopathy Progression.}, author={Wai KM and Saroj N and Boucher N and Aggarwal N and Ho AC and Rahimy E}, journal={Ophthalmic Surg Lasers Imaging Retina}, volume={54}, number={3}, pages={158-165}}"}}, {"_id": "35351535", "pmid": 35351535, "title": "Effect of metformin as an add-on therapy on neuregulin-4 levels and vascular-related complications in adolescents with type 1 diabetes: A randomized controlled trial.", "journal": "Diabetes Res Clin Pract", "authors": ["Elbarbary NS", "Ismail EAR", "Ghallab MA"], "date": "2022-04-01T00:00:00Z", "doi": "10.1016/j.diabres.2022.109857", "meta_date_publication": "2022 Apr", "meta_volume": "186", "meta_issue": "", "meta_pages": "109857", "score": 50251.953, "text_hl": "METHODS: This randomized placebo-controlled trial included 80 @DISEASE_Diabetes_Mellitus_Type_1 @DISEASE_MESH:D003922 @@@type 1 diabetic@@@ @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_603933</m> @DISEASE_OMIM:603933 @@@microvascular complications@@@ who were randomly divided to receive either 24 weeks of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 500 mg/day or matching placebo. ", "citations": {"NLM": "Elbarbary NS, Ismail EAR, Ghallab MA. Effect of metformin as an add-on therapy on neuregulin-4 levels and vascular-related complications in adolescents with type 1 diabetes: A randomized controlled trial. Diabetes Res Clin Pract. 2022 Apr;186():109857. PMID: 35351535", "BibTeX": "@article{35351535, title={Effect of metformin as an add-on therapy on neuregulin-4 levels and vascular-related complications in adolescents with type 1 diabetes: A randomized controlled trial.}, author={Elbarbary NS and Ismail EAR and Ghallab MA}, journal={Diabetes Res Clin Pract}, volume={186}, pages={109857}}"}}, {"_id": "35779798", "pmid": 35779798, "title": "Positive regulation of endothelial Tom70 by metformin as a new mechanism against cardiac microvascular injury in diabetes.", "journal": "Mitochondrion", "authors": ["Hou J", "Wang X", "Li Y", "Hou J", "Li X", "Zhang X", "Pei H", "Yang D"], "date": "2022-07-01T00:00:00Z", "doi": "10.1016/j.mito.2022.06.005", "meta_date_publication": "2022 Jul", "meta_volume": "65", "meta_issue": "", "meta_pages": "150-160", "score": 50251.617, "text_hl": "The purpose of this study was to demonstrate the protective effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_603933</m> @DISEASE_OMIM:603933 @@@diabetic cardiac microvascular injury@@@ and to identify the role of @GENE_TOMM70A @GENE_28185 @@@Tom70@@@ in this effect. ", "citations": {"NLM": "Hou J, Wang X, Li Y, Hou J, Li X, Zhang X, Pei H, Yang D. Positive regulation of endothelial Tom70 by metformin as a new mechanism against cardiac microvascular injury in diabetes. Mitochondrion. 2022 Jul;65():150-160. PMID: 35779798", "BibTeX": "@article{35779798, title={Positive regulation of endothelial Tom70 by metformin as a new mechanism against cardiac microvascular injury in diabetes.}, author={Hou J and Wang X and Li Y and Hou J and Li X and Zhang X and Pei H and Yang D}, journal={Mitochondrion}, volume={65}, pages={150-160}}"}}, {"_id": "32774367", "pmid": 32774367, "pmcid": "PMC7396103", "title": "Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes", "journal": "Int J Endocrinol", "authors": ["Chin SO", "Ha IG", "Rhee SY", "Jeong SJ", "Chon S", "Kim SH", "Ahn KJ", "Baik SH", "Park Y", "Nam MS", "Lee KW", "Woo JT"], "date": "2020-07-24T00:00:00Z", "doi": "10.1155/2020/9879517", "meta_date_publication": "2020", "meta_volume": "2020", "meta_issue": "", "meta_pages": "9879517", "score": 50249.945, "text_hl": "...Difference of @<m>DISEASE_603933</m> @DISEASE_OMIM:603933 @@@microvascular complication of diabetes@@@ according to the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@.", "citations": {"NLM": "Chin SO, Ha IG, Rhee SY, Jeong SJ, Chon S, Kim SH, Ahn KJ, Baik SH, Park Y, Nam MS, Lee KW, Woo JT. Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes Int J Endocrinol. 2020;2020():9879517. PMID: 32774367", "BibTeX": "@article{32774367, title={Clinical Characteristics and Prevalence of Comorbidities according to Metformin Use in Korean Patients with Type 2 Diabetes}, author={Chin SO and Ha IG and Rhee SY and Jeong SJ and Chon S and Kim SH and Ahn KJ and Baik SH and Park Y and Nam MS and Lee KW and Woo JT}, journal={Int J Endocrinol}, volume={2020}, pages={9879517}}"}}, {"_id": "26377054", "pmid": 26377054, "pmcid": "PMC4623946", "title": "Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications: the DPP Outcomes Study", "journal": "Lancet Diabetes Endocrinol", "authors": ["Diabetes Prevention Program Research Group"], "date": "2015-11-01T00:00:00Z", "doi": "10.1016/S2213-8587(15)00291-0", "meta_date_publication": "2015 Nov", "meta_volume": "3", "meta_issue": "11", "meta_pages": "866-75", "score": 50062.383, "text_hl": "Long-term Effects of Lifestyle Intervention or @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ on @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@Diabetes@@@ Development and @<m>DISEASE_603933</m> @DISEASE_OMIM:603933 @@@Microvascular Complications@@@: the DPP Outcomes Study", "citations": {"NLM": "Diabetes Prevention Program Research Group. Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications: the DPP Outcomes Study Lancet Diabetes Endocrinol. 2015 Nov;3(11):866-75. PMID: 26377054", "BibTeX": "@article{26377054, title={Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications: the DPP Outcomes Study}, author={Diabetes Prevention Program Research Group}, journal={Lancet Diabetes Endocrinol}, volume={3}, number={11}, pages={866-75}}"}}, {"_id": "29854819", "pmid": 29854819, "pmcid": "PMC5952500", "title": "Association of Metformin Treatment with Reduced Severity of Diabetic Retinopathy in Type 2 Diabetic Patients", "journal": "J Diabetes Res", "authors": ["Li Y", "Ryu C", "Munie M", "Noorulla S", "Rana S", "Edwards P", "Gao H", "Qiao X"], "date": "2018-04-30T00:00:00Z", "doi": "10.1155/2018/2801450", "meta_date_publication": "2018", "meta_volume": "2018", "meta_issue": "", "meta_pages": "2801450", "score": 50057.227, "text_hl": "These evidences pointed to a potential effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on benefiting @<m>DISEASE_603933</m> @DISEASE_OMIM:603933 @@@microvascular complications@@@ of @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ such as @DISEASE_Diabetic_Retinopathy @DISEASE_MESH:D003930 @@@DR@@@. ", "citations": {"NLM": "Li Y, Ryu C, Munie M, Noorulla S, Rana S, Edwards P, Gao H, Qiao X. Association of Metformin Treatment with Reduced Severity of Diabetic Retinopathy in Type 2 Diabetic Patients J Diabetes Res. 2018;2018():2801450. PMID: 29854819", "BibTeX": "@article{29854819, title={Association of Metformin Treatment with Reduced Severity of Diabetic Retinopathy in Type 2 Diabetic Patients}, author={Li Y and Ryu C and Munie M and Noorulla S and Rana S and Edwards P and Gao H and Qiao X}, journal={J Diabetes Res}, volume={2018}, pages={2801450}}"}}, {"_id": "10860188", "pmid": 10860188, "title": "Optimal glycemic control in type 2 diabetic patients. Does including insulin treatment mean a better outcome?", "journal": "Diabetes Care", "authors": ["Vaaler S"], "date": "2000-04-01T00:00:00Z", "meta_date_publication": "2000 Apr", "meta_volume": "23 Suppl 2", "meta_issue": "", "meta_pages": "B30-4", "score": 50044.965, "text_hl": "Both @CHEMICAL_Sulfonylurea_Compounds @CHEMICAL_MESH:D013453 @@@sulfonylurea@@@ and @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ have been shown to significantly reduce the risk of @<m>DISEASE_603933</m> @DISEASE_OMIM:603933 @@@microvascular complications@@@. ", "citations": {"NLM": "Vaaler S. Optimal glycemic control in type 2 diabetic patients. Does including insulin treatment mean a better outcome? Diabetes Care. 2000 Apr;23 Suppl 2():B30-4. PMID: 10860188", "BibTeX": "@article{10860188, title={Optimal glycemic control in type 2 diabetic patients. Does including insulin treatment mean a better outcome?}, author={Vaaler S}, journal={Diabetes Care}, volume={23 Suppl 2}, pages={B30-4}}"}}, {"_id": "28770322", "pmid": 28770322, "title": "Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.", "journal": "Diabetologia", "authors": ["Aroda VR", "Knowler WC", "Crandall JP", "Perreault L", "Edelstein SL", "Jeffries SL", "Molitch ME", "Pi-Sunyer X", "Darwin C", "Heckman-Stoddard BM", "Temprosa M", "Kahn SE", "Nathan DM", "Diabetes Prevention Program Research Group"], "date": "2017-09-01T00:00:00Z", "doi": "10.1007/s00125-017-4361-9", "meta_date_publication": "2017 Sep", "meta_volume": "60", "meta_issue": "9", "meta_pages": "1601-1611", "score": 50044.523, "text_hl": "Participants originally assigned to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ continued to receive @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, unmasked. ", "citations": {"NLM": "Aroda VR, Knowler WC, Crandall JP, Perreault L, Edelstein SL, Jeffries SL, Molitch ME, Pi-Sunyer X, Darwin C, Heckman-Stoddard BM, Temprosa M, Kahn SE, Nathan DM, Diabetes Prevention Program Research Group. Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study. Diabetologia. 2017 Sep;60(9):1601-1611. PMID: 28770322", "BibTeX": "@article{28770322, title={Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.}, author={Aroda VR and Knowler WC and Crandall JP and Perreault L and Edelstein SL and Jeffries SL and Molitch ME and Pi-Sunyer X and Darwin C and Heckman-Stoddard BM and Temprosa M and Kahn SE and Nathan DM and Diabetes Prevention Program Research Group}, journal={Diabetologia}, volume={60}, number={9}, pages={1601-1611}}"}}]}